ELLI, FRANCESCA MARTA
ELLI, FRANCESCA MARTA
Dipartimento di Scienze Cliniche e di Comunità
Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program
2024 F.M. Elli, D. Mattinzoli, M. Ikehata, F. Bagnaresi, M.A. Maffini, G. Del Sindaco, A. Pagnano, C. Lucca, P. Messa, M. Arosio, G. Castellano, C.M. Alfieri, G. Mantovani
Novel pathogenetic variants in PTHLH and TRPS1 genes causing syndromic brachydactyly
2022 F.M. Elli, D. Mattinzoli, C. Lucca, M. Piu, M.A. Maffini, J. Costanza, L. Fontana, C. Santaniello, C. Forino, D. Milani, M.T. Bonati, A. Secco, R. Gastaldi, C. Alfieri, P. Messa, M. Miozzo, M. Arosio, G. Mantovani
Fibroblast growth factor 23 level modulates the hepatocyte’s alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB
2022 D. Mattinzoli, M. Li, G. Castellano, M. Ikehata, S. Armelloni, F.M. Elli, P. Molinari, K. Tsugawa, C.M. Alfieri, P. Messa
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells
2021 R. Catalano, E. Giardino, D. Treppiedi, F. Mangili, V. Morelli, F.M. Elli, A.L. Serban, M. Luconi, M. Mannelli, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications
2021 L. Mazoni, M. Apicella, F. Saponaro, G. Mantovani, F.M. Elli, S. Borsari, E. Pardi, P. Piaggi, C. Marcocci, F. Cetani
Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?
2021 F.M. Elli, G. Mantovani
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
2020 E. Giardino, R. Catalano, F. Mangili, A.M. Barbieri, D. Treppiedi, F.M. Elli, A. Dolci, A. Contarino, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients
2020 G. Mantovani, M. Bastepe, D. Monk, L. de , Sanctis, S. Thiele, S. , F. Ahmed, R. Bufo, T. Choplin, G. De , Filippo, G. Devernois, T. Eggermann, Francesca , M. Elli, A. Garcia , R. Emily , L. Germain-Lee, L. Groussin, Neveen , A.T. Hamdy, P. Hanna, O. Hiort, H. Jüppner, P. Kamenický, N. Knight, E. Le , Norcy, B. Lecumberri, Michael , A. Levine, O. Mäkitie, R. Martin, Gabriel , Á. Martos-Moreno, M. Minagawa, P. Murray, A. Pereda, R. Pignolo, L. Rejnmark, R. Rodado, A. Rothenbuhler, V. Saraff, Ashley , H. Shoemaker, Eileen , M. Shore, C. Silve, S. Turan, P. Woods, M. , C. Zillikens, G. Perez , D. Nanclares, A. Linglart
Improved Molecular Diagnosis of McCune-Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR
2019 F.M. Elli, L. de Sanctis, M. Bergallo, M.A. Maffini, A. Pirelli, I. Galliano, P. Bordogna, M. Arosio, G. Mantovani
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation
2019 D. Mattinzoli, M. Ikehata, K. Tsugawa, C.M. Alfieri, M. Barilani, L. Lazzari, P. Andreetta, F.M. Elli, G. Mantovani, P. Messa
Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman
2019 P. Del Monte, C.M. Cuttica, A. Marugo, L. Foppiani, D. Audenino, T.T. Godowicz, F.M. Elli, G. Mantovani, E. Di Maria
Hypercalcitoninaemia in pseudohypo-parathyroidism type 1A and type 1B
2019 M.P. Yavropoulou, E. Chronopoulos, G. Trovas, E. Avramidis, F.M. Elli, G. Mantovani, P. Zebekakis, J.G. Yovos
Inactivating PTH/PTHrP Signaling Disorders
2019 G. Mantovani, F.M. Elli
2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance
2019 F.M. Elli, L. de Sanctis, B. Madeo, M.A. Maffini, P. Bordogna, A. Pirelli, M. Arosio, G. Mantovani
Association of GNAS Imprinting Defects and Deletions of Chromosome 2 in Two Patients : Clues Explaining Phenotypic Heterogeneity in Pseudohypoparathyroidism Type 1B/iPPSD3
2019 F.M. Elli, L. Desanctis, M.A. Maffini, P. Bordogna, D. Tessaris, A. Pirelli, M. Arosio, A. Linglart, G. Mantovani
Diagnosis and management of pseudohypoparathyroidism and related disorders: First international Consensus Statement
2018 G. Mantovani, M. Bastepe, D. Monk, L. De Sanctis, S. Thiele, A. Usardi, S.F. Ahmed, R. Bufo, T. Choplin, G. De Filippo, G. Devernois, T. Eggermann, F.M. Elli, K. Freson, A. García Ramirez, E.L. Germain-Lee, L. Groussin, N. Hamdy, P. Hanna, O. Hiort, H. Jüppner, P. Kamenický, N. Knight, M. Kottler, E. Le Norcy, B. Lecumberri, M.A. Levine, O. Mäkitie, R. Martin, G.Á. Martos-Moreno, M. Minagawa, P. Murray, A. Pereda, R. Pignolo, L. Rejnmark, R. Rodado, A. Rothenbuhler, V. Saraff, A.H. Shoemaker, E.M. Shore, C. Silve, S. Turan, P. Woods, M. Carola Zillikens, G.P. De Nanclares, A. Linglart
Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases
2018 F. Elli, P. Bordogna, M. Arosio, A. Spada, G. Mantovani
Genetic and epigenetic defects at the GNAS locus lead to distinct patterns of skeletal growth but similar early-onset obesity
2018 P. Hanna, V. Grybek, G. de Nanclares, L. Tran, L. de Sanctis, F. Elli, J. Errea, B. Francou, P. Kamenicky, L. Linglart, A. Pereda, A. Rothenbuhler, D. Tessaris, S. Thiele, A. Usardi, A. Shoemaker, M. Kottler, H. Jüppner, G. Mantovani, A. Linglart
Parathyroid hormone resistance syndromes – Inactivating PTH/PTHrP signaling disorders (iPPSDs)
2018 F.M. Elli, A. Pereda, A. Linglart, G. Perez de Nanclares, G. Mantovani
Multiple hormone resistance and alterations of GPCRs signaling
2018 G. Mantovani, F.M. Elli